Wargowski, Ellen
Johnson, Laura E.
Eickhoff, Jens C.
Delmastro, Lauren
Staab, Mary Jane
Liu, Glenn
McNeel, Douglas G.
Funding for this research was provided by:
National Cancer Institute (P30 CA014520)
Article History
Received: 18 January 2018
Accepted: 28 February 2018
First Online: 13 March 2018
Ethics approval and consent to participate
: The study protocol was reviewed and approved by all local (University of Wisconsin Human Subjects’ Review Board (IRB), UW protocol CO11816), and federal (FDA, NIH Recombinant DNA Advisory Committee) entities. All patients gave written informed consent for participation. The trial national registration number is NCT01706458.
: Not applicable.
: Douglas G. McNeel has ownership interest, has received research support, and serves as consultant to Madison Vaccines, Inc. which has licensed intellectual property related to this content. None of the other authors have relevant potential conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.